Baxter and Premier’s ProvideGx™ Subsidiary Collaborate to Address Drug Shortages

Go back to Baxter and Premier’s ProvideGx™ Subsidiary Collaborate to Address Drug Shortages

Premier, Inc. (PINC) PT Lowered to $41 at Cowen

February 7, 2019 8:22 AM EST

Cowen analyst Charles Rhyee lowered the price target on Premier, Inc. (NASDAQ: PINC) to $41.00 (from $43.00) while maintaining a Market Perform rating.

... More